Clinical Trial Update: Alzheimer's Disease - Input of Vitamin D With mEmantine Assay [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the addition of Vitamin D to memantine for Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Memantine (memantine)
• Vitamin D (Cholecalciferol)

Snippet

Sponsor: University Hospital, Angers | Conditions: Alzheimer Disease | Phase 3 | Status: COMPLETED